Events

Upcoming Neuroscience Events

UK CNS Metabolism COBRE

CNS Metabolism Symposium

Registration is now open!  The University of Kentucky CNS Metabolism COBRE is hosting a one-day Symposium on Monday, December 9th in the Healthy Kentucky Research Building.

The CNS Metabolism Symposium will feature Keynote speaker Dr. Roberta Brinton and the innovative work of multiple early-stage researchers to explore how metabolism influences brain function and disease. Don't miss the chance to engage with cutting-edge research and connect with a vibrant community of cerebral metabolism experts.

2024 N-CTRS

2024 Neuroscience Clinical-Translational Research Symposium

The annual Neuroscience CTRS will be held in-person on October 24-25, 2024, in the Healthy Kentucky Research Building.

This year's Keynote Speaker is Dr. Katherine Hartmann, the new Director of UK's Center for Clinical and Translational Science (CCTS).

Thank you all for attending!
 

neuroscience conference KNI research symposium

 

Past Events and Conference Materials

Neuroscience Clinical-Translational Research Symposium

An annual daylong symposium that provides the opportunity for basic, translational, and clinical neuroscience investigators including trainees, researchers, and program directors throughout the university to discuss their work, share progress, and develop collaborations. Choose a year below to access previous abstracts.

2023      2022       2020       2019       2018       2017       2016

 

neuroscience news archive healthcare research NRPA

 

2024

Specialized neurologic care enhances quality of life for children, families

UK researchers find Alzheimer’s-like brain changes in long COVID patients

MAMMA Alliance supports 4 innovative mobile health projects

NIH funds UK’s groundbreaking DBS-Plus trial for Parkinson’s

Sanders-Brown Center on Aging launches innovative Brain Health Activities program

Sanders-Brown research shows clear connection between socialization, enrichment and brain health

Patrick Sullivan: 2024-25 University Research Professor Q&A

UK study links nanoparticles to oxidative stress and neuron death

UK researcher studies how cerebellum may influence thirst

UK’s Tong, Yang and Yi winners in NIH TARGETED Challenge

UK neurologist advocates for AI, ultrasound to help prevent blindness from giant cell arteritis

Sanders-Brown study: Long-read RNA sequencing reveals key gene expressions in Alzheimer’s disease

Addressing disparities in Alzheimer's disease through culturally tailored health information

People Behind Our Research: Lauren Whitehurst explores how sleep impacts health, wellbeing

UK HealthCast: Essential Info for Treatment of Pediatric Stroke Patients

$3.1 million NIA grant to advance Sanders-Brown researcher’s groundbreaking dementia study

Understanding Parkinson's Disease: Symptoms, Causes and Management

UK HealthCare Women's History Month Q&A: Wang-Xia Wang

UK researchers explore the relationship between Down syndrome and Alzheimer's disease

Linda Van Eldik, Sanders-Brown, featured prominently in AARP

Chemicals in plastics could be a risk factor for Alzheimer’s

Caring for the caregiver: UK neurology helps patient overcome rare condition

Goldstein selected to help lead statewide task force addressing heart disease and stroke

AI helps bring vital stroke care ‘virtually to the patient’s bedside’

Patient finds answers and hope thanks to dedicated UK neurology team

2023

Police sergeant ‘making full use of the life he got back’ thanks to UK HealthCare

‘The more I learned about it, the more I was drawn in’

“You’re not alone.”

Sanders-Brown builds upon strong reputation in Alzheimer’s research, care and outreach

‘It’s literally a dream come true’: Dr. Randaline Barnett returns home to serve as pediatric neurosurgeon

UK’s Goldstein leads new scientific statement by the American Heart Association

UK HealthCare/Norton Healthcare – Stroke Care Network adds 3 affiliates, bringing total to 40

NIH awards $10.6 million for central nervous system metabolism research center at UK

UK researchers 1st to show multiple sclerosis drug can be used as Alzheimer’s therapy

Sanders-Brown Center on Aging featured in special on WKYT this Monday

Work by UK neurologist to improve access to multiple sclerosis treatments accepted by WHO

New study shows anti-inflammatory drugs as a promising target for Alzheimer’s disease

Drug studied at UK is 1st disease-modifying therapy in U.S. approved to treat Alzheimer’s

UK social work researcher to study effects of PTSD on dementia

UK researchers receive funding to study how genetic factors contribute to dementia

Sanders-Brown publication makes cover of recent Journal of Neuroscience issue

Women Making History: UK researcher helps caregivers navigate Alzheimer's challenges

Rare Disease Day spotlight: A new approach to studying Moyamoya syndrome

Promising Alzheimer's drug being studied at UK's Sanders-Brown Center on Aging receives FDA approval

Pat Summitt Foundation awards grant to University of Kentucky Sanders-Brown Center on Aging

Why are human brains so powerful? UK, Hebrew University partner to find out

2022

UK's Sanders-Brown among 1st locations testing promising new Alzheimer's drug

Sanders-Brown researcher receives $1.7 million to study adverse effects of Alzheimer’s drugs

UK researcher explores multisensory approach as potential treatment for Alzheimer’s patients

Sanders-Brown researchers receive $20.5 million from National Institute on Aging

Sanders-Brown director receives funding to advance work

UK Develops Support for People With Mild Cognitive Impairment, Caregivers

Researchers Develop Online Portal to Show How Biases in RNA Sequences Affect Gene Expression

UK Researcher Highlights Need to Improve Alzheimer's and Dementia Cognitive Screenings and Assessments

UK Study Identifies Therapeutic Targets for Alzheimer’s Disease

Study Indicates High Prevalence of Recently Defined Non-Alzheimer’s Dementia

Students Organize 1st ‘Neuroscience Gala’ at UK in Honor of Former Advisor

UK Begins 1st Clinical Trial in the World for Newly Discovered Form of Dementia

Sanders-Brown Study Looks at Blood Test as Possible Diagnostic Tool for Alzheimer’s Disease

Personal Experience Ignites UK Coach Kyra Elzy's Passion for Alzheimer’s Research

UK Sanders-Brown Center on Aging Director Appointed to National Council

UK Researchers Link a New Non-Mutated Protein to Dementia

UK Program Improving the Lives of Children With Disabilities

New Sanders-Brown Center on Aging Memory Clinic: Expanding Research, Enhancing Patient Care

Sanders-Brown Researcher Combines Love of Science and Family at UK

2021

Researchers Map Glycosylation Patterns Associated With Alzheimer’s Disease

Researchers Look at Issue of Data Redundancy in Machine Learning

UK's Sanders-Brown Receives Continued Funding to Research Vascular Cognitive Impairment and Dementia Biomarkers

'UK at the Half': Sanders-Brown Making UK a Global Leader in Aging Disease Research

Study Suggests Personalized Medicine May be the Future of Alzheimer’s Disease Treatment

UK Sanders-Brown Center on Aging Receives $14.5 Million to Continue Alzheimer's Disease Research and Outreach

UK Study: Healthy Dietary Intake Associated With Lower Brain Iron, Better Cognition in Older Adults

African American Research Training Scholars Present Neuroscience Research at 1st Symposium

Recent Study Identifies 11 Candidate Genetic Variants for Alzheimer’s Disease

Kentucky LEND to Train Providers to Serve Children with Neurodevelopmental Disabilities

UK Neuroscience Research Priority Area Brings Diverse Groups Together to Advance Studies

UK HealthCare, Partners Receive Prestigious CDC Grant to Improve Stroke Care, Outcomes in Kentucky

UK’s Sanders-Brown Researchers Discover Polyamines Prevent Collection of Alzheimer’s Disease Protein

New UK Research May Offer Hope for Alzheimer’s Patients

University of Kentucky Researchers Discover Fundamental Roles of Glucosamine in Brain

UK Doctor's Need to Help Loved One Inspires New Sanders-Brown Video Series

Goldstein Elected to American Academy of Neurology Board of Directors

Sanders-Brown Hosts Discussion & Screening of Documentary Highlighting Robin Williams' Undiagnosed Dementia

Experimental Treatment Shows Promise in Treating Traumatic Brain Injury

Research Looks at Impact of Patient Sex on Treatment Strategies for Spinal Cord Injuries

Research Establishes a New Method to Predict Individual Risk of Cognitive Decline

UK Researcher Finds Alzheimer’s Patients ‘Get Hooked on a Feeling’ With Music

UK Study Potentially Links Low Blood Amylin Level to Reduced Progression of Alzheimer’s Disease

2020

UK’s Sanders-Brown Center on Aging Director Elected as AAAS Fellow

'Behind the Blue': Dr. Peter Nelson Discusses UK’s Leading Efforts on Alzheimer’s and Dementia Research

Multi-Million Dollar Multidisciplinary Grant Supports Advancement of Epilepsy Research

Butterfield Recognized as a Leading Alzheimer’s Expert

New Study Looks at Encoding the Odor of Cigarette Smoke

Sanders-Brown Research Discovers New Pathway in TDP-43 Related Dementias

Sanders-Brown Study Leads to Potential New Treatment Approach for Alzheimer’s Disease

UK’s Sanders-Brown, Penn Researchers Provide Insights into Newly Characterized Form of Dementia

UK Research Center Establishes Scholar Program to Promote Diversity in Neurotrauma Studies

Important Dementia Studies Continuing at UK Despite Ongoing COVID-19 Pandemic

Researchers Publish Study Looking at Approaches to Better Treat Alzheimer's Disease

UK Receives $3.2 Million for Traumatic Brain Injury Research

UK Sanders-Brown Center on Aging Facilitates First Participant in Worldwide Drug Study

Sanders-Brown Researcher Receives Grant Supported by Rotary Clubs to Further Dementia Studies

It’s Not Just Alzheimer’s Disease: Sanders-Brown Research Highlights Form of Severe Dementia

UK Receives Prestigious Grant from National Institute of Neurological Disorders

Sanders-Brown Director Leads First Human Study of Drug Targeting Brain Inflammation

Free Radical Discovery a Hallmark of Allan Butterfield’s 45-Year Research Career

Kitzman Receives National Award for Outstanding Advocacy in Neurologic Therapy

UK Research Could Help Predict Progression of Parkinson's Disease

Chemistry Researcher Develops Innovative Testing, Potential Remedies for Head Trauma, Alzheimer's

Antibiotics Could Be Promising Treatment for Form of Dementia

UK Honors Sanders-Brown Center on Aging Researchers

Gut Microbes May Improve Stroke Recovery

2018

Blood, BBQ, and Ancestry.com: How One UK Neurologist Tracks Familial ALS

A Stroke at Age 27 Inspired Dedication to Cardiovascular Research

UK Study: Amphetamines Don't Improve Motor Recovery After Stroke

Sanders-Brown Grant Trains New Generation of Dementia Researchers

Research Shows More Seniors Are Happy Despite Cognitive Decline

Mice with Frequent Flyer Miles Advance the Alzheimer's Cause

Research Identifies Potential Predictors of Vascular Cognitive Impairment and Dementia in Alzheimer's

Wonder Women: Young Scientists Help Confirm Presence of Breathing "Ghost Network"

New Options for Parkinson's Patients

Head Injuries and the Path from Pilot Study to Major Grant

New Study Gives a Closer Look at Blood-Brain Barrier Dysfunction in Epilepsy

New Clinical Trial Takes Personalized Approach for Rare Type of ALS in Appalachia

KNI Neurologist's Work Featured in Major National News Outlet

Gentry Receives National Award for Outstanding Mentorship

UK Biochemist Recognized for Work in FUS-ALS

Two Sanders-Brown Studies Show Connection Between Diet, Cognitive Function

New Options for Parkinson's Patients

Young Stroke Patient Baffles and Surprises Doctors

Two Strokes and Three Surgeries Later, Lexington Teen Set to Graduate High School

UK Researchers Study Rapid Blood Test for Concussions

Beloved Dog and UK Healthcare's Comprehensive Stroke Center Save Patient

Novel Use of Spinal Cord Stimulation is Life Changing for UK Geologist and Patient

College of Health Sciences Aphasia Lab Helps Stroke, TBI Survivors Find Their Voice